These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1382040)

  • 41. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system.
    Fujiwara H; Aoki H; Yoshioka T; Tomita S; Ikegami R; Hamaoka T
    J Immunol; 1984 Jul; 133(1):509-14. PubMed ID: 6233375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hapten-specific cellular immune response producing glomerular injury.
    Oite T; Shimizu F; Kagami S; Morioka T
    Clin Exp Immunol; 1989 Jun; 76(3):463-8. PubMed ID: 2473861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of age-associated immune dysfunction in mucosal-associated lymph nodes.
    Szewczuk MR; Campbell RJ; Jung LK
    J Immunol; 1981 Jun; 126(6):2200-4. PubMed ID: 6164724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monophosphoryl lipid A behaves as a T-cell-independent type 1 carrier for hapten-specific antibody responses in mice.
    Myers KR; Beining P; Betts M; Snippe H; Inman J; Golding B
    Infect Immun; 1995 Jan; 63(1):168-74. PubMed ID: 7806354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LPS greatly enhances the antibody response to hapten-polysaccharide conjugates, but not to hapten-protein conjugates.
    Mäkelä O; Seppälä IJ; Vaara M
    Ann Immunol (Paris); 1983; 134D(1):25-36. PubMed ID: 6194741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on active immunization with self antigens. II. Production of antibody related to hapten substitution.
    Mahana W; Guilbert B; Gonzalez R; Avrameas S
    Scand J Immunol; 1989 Sep; 30(3):303-13. PubMed ID: 2781246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of auto-anti-idiotypic antibody during the normal immune response. IX. Characteristics of the auto-anti-idiotype antibody and its production.
    Goidl EA; Samarut C; Schneider-Gadicke A; Hochwald NL; Thorbecke GJ; Siskind GW
    Cell Immunol; 1984 Apr; 85(1):25-33. PubMed ID: 6201287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional characterization of hapten-specific suppressor cells.
    Zöller M; Wigzell H; Andrighetto G
    Scand J Immunol; 1985 Jul; 22(1):73-82. PubMed ID: 3161175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of heterogeneities of antitrinitrophenyl antibodies in strains of mice immunized by various methods.
    Kamiya-Harada Y; Kawakami M
    Microbiol Immunol; 1979; 23(12):1199-209. PubMed ID: 317124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigen-induced and polyclonal B-cell responses in human peripheral blood lymphocyte cultures.
    Galanaud P; Crevon MC; Delfraissy JF; Rannou MT; Richard Y; Emilie D; Vazquez A
    Cell Immunol; 1987 May; 106(2):234-41. PubMed ID: 3494539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potentiation of antibody responses by specific IgM: specificity and thymus dependency.
    Collisson EW; Anderson B; Rönnholm M; Lamon EW
    Cell Immunol; 1983 Jul; 79(1):44-55. PubMed ID: 6190581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The immune response of CBA/N mice and their F1 hybrids to 2,4,6-trinitrophenylated antigens. II. Avidity profiles of secondary IgM and IgG responses to TNP-KLH.
    Quan ZS; Satin AJ; Quintáns J
    Cell Immunol; 1981 Jul; 61(2):448-52. PubMed ID: 7018702
    [No Abstract]   [Full Text] [Related]  

  • 54. Induction in vivo of enhancing factors for antibody production. I. The presence of antigen-specific helper factor(s) in the serum of mice 6 hours after antigenic stimulation.
    Lee ST; Paraskevas F
    Cell Immunol; 1981 May; 60(1):64-76. PubMed ID: 6165487
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of anti-hapten antibody plaque-forming cells by a chemically reactive hapten.
    Huchet R; Grandjon D
    Ann Inst Pasteur Immunol; 1988; 139(2):135-42. PubMed ID: 3285857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence of IgG-mediated enhancement of the antibody response in vivo without complement activation via the classical pathway.
    Wiersma EJ; Nose M; Heyman B
    Eur J Immunol; 1990 Dec; 20(12):2585-9. PubMed ID: 2269326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterologous carriers in the anamnestic antihapten response.
    Rittenberg MB; Campbell DH
    J Exp Med; 1968 Apr; 127(4):717-30. PubMed ID: 4171054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of the antibody response to protein antigens by specific IgG under different experimental conditions.
    Wiersma EJ
    Scand J Immunol; 1992 Aug; 36(2):193-200. PubMed ID: 1502494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TNP-LPS induces an IgG anti-TNP immune response in mice.
    Humbert J; Motta I; Truffa-Bachi P
    Cell Immunol; 1979 Sep; 47(1):211-7. PubMed ID: 315823
    [No Abstract]   [Full Text] [Related]  

  • 60. Dual immunoregulatory effects of monoclonal IgG-antibodies: suppression and enhancement of the antibody response.
    Wiersma EJ; Coulie PG; Heyman B
    Scand J Immunol; 1989 Apr; 29(4):439-48. PubMed ID: 2470138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.